Free Biopharma Daily Pulse - 08/11/22
$XBI $90.78 | -3.17% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
top of page
${alertText}
Want unlimited access? Try Pro free for 7 days.
BPIQ Blog
- Aug 11, 2022
- 1 min
Biopharma Mid Morning Pulse - 08/11/22
(Posted 10:20am CST) $XBI $93.28| -0.47% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
- Aug 11, 2022
- 1 min
Free Biopharma Mid Morning Pulse - 08/11/22
(Posted 10:20am CST) $XBI $93.28| -0.47% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
- Aug 10, 2022
- 1 min
Biopharma Daily Pulse - 08/10/22
$XBI $93.75 | +3.31% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
- Aug 10, 2022
- 1 min
Free Biopharma Daily Pulse - 08/10/22
$XBI $93.75 | +3.31% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
- Aug 10, 2022
- 1 min
Biopharma Mid Morning Pulse - 08/10/22
(Posted 10:30am CST) $XBI $92.44 | +1.86% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
- Sep 27, 2023
- 2 min
Big/Suspected Movers FAQ/User Guide
What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that...
- Aug 28, 2023
- 1 min
Quarterly Big Mover Biotech Stocks To Watch
Our free Big-Mover Report: Listing of 10 of the biggest clinical readouts this quarter Use this info: To update your holdings before a...
- Aug 17, 2023
- 1 min
Q2 2023 Product Revenue Analyses
We have gone through the Q2 2023 financial reports to analysis each companies product revenue to see: Q2 '23 revenue Q2 '22 revenue Q2...
- Aug 15, 2023
- 3 min
BPIQ Q2 2023 Biotech Hedge Fund (13F) Analysis
Last updated 8/15/23 Summary: Hedge fund holdings can help you discover new investment ideas Get more stock idea and see the full list of...
- Aug 7, 2023
- 1 min
SYFOVRE (APLS) vs. IZERVAY (Astellas)
Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...
- Aug 7, 2023
- 1 min
BIIB & SAGE: Zuranolone
Big PDUFA from a big collaboration: BIIB & SAGE PDUFA - 8/5/23 - Zuranolone in MDD & PPD Collaboration since 2020… BIIB invested $1.5B in...
- Jul 31, 2023
- 1 min
Apellis Pharmaceuticals (APLS)
BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page